Analisi sito web timmermanreport.com
TimmermanReport.com - Your Edge In Biotech
Generato il Aprile 05 2026 03:40 AM
Statistiche non aggiornate? AGGIORNA !
Il punteggio e 55/100
SEO Content
Title
TimmermanReport.com - Your Edge In Biotech
Lunghezza : 42
Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Description
Timmerman Report is an independently-owned subscription publication that provides timely, in-depth biotech news and analysis.
Lunghezza : 125
Grande, la tua meta description contiene tra 70 e 160 caratteri.
Keywords
Molto male. Non abbiamo trovato meta keywords nella tua pagina. Usa questo generatore gratuito online di meta tags per creare keywords.
Og Meta Properties
Buono, questa pagina sfrutta i vantaggi Og Properties.
| Proprieta | Contenuto |
|---|---|
| locale | en_US |
| type | website |
| title | TimmermanReport.com - Your Edge In Biotech |
| description | Timmerman Report is an independently-owned subscription publication that provides timely, in-depth biotech news and analysis. |
| url | https://timmermanreport.com/ |
| site_name | Timmerman Report |
| image | https://timmermanreport.com/wp-content/uploads/2015/01/LittleTahoma.jpg |
| image:width | 800 |
| image:height | 600 |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 0 | 22 | 7 | 0 | 0 |
- [H3] Lilly Buys Centessa, Takeda & Alumis Tyk2 Showdown, & Blackstone’s Megafund
- [H3] Sleep Medicine Heats Up, as Lilly Enters Arena with Takeda, Alkermes
- [H3] Inspired by Mother Nature, Discovering New Drugs: Viswa Colluru on The Long Run
- [H3] Merck Snaps Up New Cancer Drug, Denali Grows Up, & Gilead’s TCE Wager
- [H3] Merck’s Davis-Era Acquisitions: Enough for Life After Keytruda?
- [H3] Europe’s Biotech Investment Crisis: Otello Stampacchia on The Long Run
- [H3] Servier Buys Day One, Vertex Hits IgAN Phase III, & Prasad’s Unceremonious Exit at FDA
- [H3] What the Timmerman Traverse Is All About
- [H3] Eli Lilly’s Last 20 Acquisitions, and the Opportunity for More
- [H3] Candid Goes Public, Uniqure’s FDA Dispute, & Moderna’s Big Legal Bill
- [H3] Biotech’s Deep Pool of Midsized Companies
- [H3] T-cell Engagers for Autoimmune Disease: Ken Song on The Long Run
- [H3] Agency: The Motivational Currency of Health
- [H3] Gilead Acquires Arcellx, Alkermes Passes the Torch, Beam Borrows Big
- [H3] Enjoy the Photos: Timmerman Traverse for Damon Runyon Kilimanjaro 2026
- [H3] FDA Flip-Flops on Flu Vaccine, Compass Passes Phase 3, & J&J Bets on Pennsylvania
- [H3] Discovering Drugs for Cancer and Autoimmunity: Ansu Satpathy
- [H3] Hike the High Sierras for Damon Runyon Cancer Research
- [H3] Gear Check: Timmerman Traverse for Damon Runyon Heads to Kilimanjaro
- [H3] Can We Ride the GenAI Wave Without Getting Subsumed by It?
- [H3] Your account
- [H3] What Readers Are Saying
- [H4] Download the Report
- [H4] Visit www.dash.bio
- [H4] Download the Report Here
- [H4] Two Visions of Primary Care
- [H4] Who’s in charge?
- [H4] A Company Built on What Matters
- [H4] Bottom Line
Images
Abbiamo trovato 71 immagini in questa pagina web.
70 attributi alt sono vuoti o mancanti. Aggiungi testo alternativo in modo tale che i motori di ricerca possano comprendere meglio il contenuto delle tue immagini.
Text/HTML Ratio
Ratio : 19%
Buono, il rapporto testo/codice HTML di questa pagina e maggiore di 15, e minore di 25 percento.
Flash
Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Iframe
Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.
SEO Links
URL Rewrite
Buono. I tuoi links appaiono friendly!
Underscores in the URLs
Abbiamo rilevato underscores nei tuoi URLs. Dovresti utilizzare trattini per ottimizzare le pagine per il tuo SEO.
In-page links
Abbiamo trovato un totale di 147 links inclusi 2 link(s) a files
| Anchor | Type | Juice |
|---|---|---|
| Traverse | Interno | Passing Juice |
| Timmerman Traverse for Damon Runyon – Sierras 2026 | Interno | Passing Juice |
| The Long Run Podcast | Interno | Passing Juice |
| About | Interno | Passing Juice |
| Speaking | Interno | Passing Juice |
| Events | Interno | Passing Juice |
| Team | Interno | Passing Juice |
| David Shaywitz | Interno | Passing Juice |
| Alex Harding | Interno | Passing Juice |
| Pedro Rafael Rosado | Interno | Passing Juice |
| Steve White | Interno | Passing Juice |
| In the News | Interno | Passing Juice |
| Testimonials | Interno | Passing Juice |
| Contact | Interno | Passing Juice |
| Subscribe | Interno | Passing Juice |
| Individual Subscriptions | Interno | Passing Juice |
| Group Subscriptions | Interno | Passing Juice |
| Lilly Buys Centessa, Takeda & Alumis Tyk2 Showdown, & Blackstone’s Megafund | Interno | Passing Juice |
| Luke Timmerman | Interno | Passing Juice |
| - | Interno | Passing Juice |
| All | Interno | Passing Juice |
| 02 Apr 2026 | Interno | Passing Juice |
| Sleep Medicine Heats Up, as Lilly Enters Arena with Takeda, Alkermes | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 31 Mar 2026 | Interno | Passing Juice |
| Subscribe Now | Interno | Passing Juice |
| Sign in to your account. | Interno | Passing Juice |
| Inspired by Mother Nature, Discovering New Drugs: Viswa Colluru on The Long Run | Interno | Passing Juice |
| - | Interno | Passing Juice |
| Enveda | Externo | Passing Juice |
| The Long Run with Luke Timmerman | Externo | Passing Juice |
| Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature | Externo | Passing Juice |
| Merck Snaps Up New Cancer Drug, Denali Grows Up, & Gilead’s TCE Wager | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 26 Mar 2026 | Interno | Passing Juice |
| Merck’s Davis-Era Acquisitions: Enough for Life After Keytruda? | Interno | Passing Juice |
| 1 | Interno | Passing Juice |
| 23 Mar 2026 | Interno | Passing Juice |
| Europe’s Biotech Investment Crisis: Otello Stampacchia on The Long Run | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 17 Mar 2026 | Interno | Passing Juice |
| European Life Sciences Coalition | Externo | Passing Juice |
| Download the Report | Externo | Passing Juice |
| www.dash.bio | Externo | Passing Juice |
| Ep196: Otello Stampacchia on Europe’s Biotech Crisis | Externo | Passing Juice |
| Servier Buys Day One, Vertex Hits IgAN Phase III, & Prasad’s Unceremonious Exit at FDA | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 12 Mar 2026 | Interno | Passing Juice |
| What the Timmerman Traverse Is All About | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 11 Mar 2026 | Interno | Passing Juice |
| Eli Lilly’s Last 20 Acquisitions, and the Opportunity for More | Interno | Passing Juice |
| 1 | Interno | Passing Juice |
| 10 Mar 2026 | Interno | Passing Juice |
| Candid Goes Public, Uniqure’s FDA Dispute, & Moderna’s Big Legal Bill | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 05 Mar 2026 | Interno | Passing Juice |
| Biotech’s Deep Pool of Midsized Companies | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 04 Mar 2026 | Interno | Passing Juice |
| T-cell Engagers for Autoimmune Disease: Ken Song on The Long Run | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 03 Mar 2026 | Interno | Passing Juice |
| in November 2021 | Interno | Passing Juice |
| alpha-sense.com/thelongrun | Externo | Passing Juice |
| Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases | Externo | Passing Juice |
| Agency: The Motivational Currency of Health | Interno | Passing Juice |
| David Shaywitz | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 27 Feb 2026 | Interno | Passing Juice |
| here | Externo | Passing Juice |
| Lore Health | Externo | Passing Juice |
| KindWellHealth | Externo | Passing Juice |
| Gilead Acquires Arcellx, Alkermes Passes the Torch, Beam Borrows Big | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 26 Feb 2026 | Interno | Passing Juice |
| Enjoy the Photos: Timmerman Traverse for Damon Runyon Kilimanjaro 2026 | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 20 Feb 2026 | Interno | Passing Juice |
| Dendrosenecio kilimanjari | Externo | Passing Juice |
| Damon Runyon Cancer Research Foundation | Externo | Passing Juice |
| FDA Flip-Flops on Flu Vaccine, Compass Passes Phase 3, & J&J Bets on Pennsylvania | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 19 Feb 2026 | Interno | Passing Juice |
| Discovering Drugs for Cancer and Autoimmunity: Ansu Satpathy | Interno | Passing Juice |
| - | Interno | Passing Juice |
| 17 Feb 2026 | Interno | Passing Juice |
| Download the Report Here | Externo | Passing Juice |
| Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery | Externo | Passing Juice |
| 1 | Interno | Passing Juice |
| 09 Feb 2026 | Interno | Passing Juice |
| LINK | Externo | Passing Juice |
| Tata Kavlashvili | Externo | Passing Juice |
| Shaohua Zhang | Externo | Passing Juice |
| Lachelle Weeks | Externo | Passing Juice |
| Antonio Laporte | Externo | Passing Juice |
| Natasha O’Brown | Externo | Passing Juice |
| Colin Magowan | Externo | Passing Juice |
| Mark Murcko | Externo | Passing Juice |
| Nadav Rosenberg | Externo | Passing Juice |
| Lisa Purcell | Externo | Passing Juice |
| David Kaufman | Externo | Passing Juice |
| Rob Crummet | Externo | Passing Juice |
| Michele LeSueur | Externo | Passing Juice |
| Carl Schoellhammer | Externo | Passing Juice |
| Tony Martignetti | Externo | Passing Juice |
| Krysta Pellegrino | Externo | Passing Juice |
| Thomas (Gus) Gustafson | Externo | Passing Juice |
| Vivek Mittal | Externo | Passing Juice |
| Anne Kasmar | Externo | Passing Juice |
| Henry Kilgore | Externo | Passing Juice |
| Hamza Sheikh | Externo | Passing Juice |
| Gear Check: Timmerman Traverse for Damon Runyon Heads to Kilimanjaro | Interno | Passing Juice |
| - | Interno | Passing Juice |
| Can We Ride the GenAI Wave Without Getting Subsumed by It? | Interno | Passing Juice |
| 1 | Interno | Passing Juice |
| Tools | Interno | Passing Juice |
| 08 Feb 2026 | Interno | Passing Juice |
| probably never | Externo | Passing Juice |
| released | Externo | Passing Juice |
| Reported | Externo | Passing Juice |
| used | Externo | Passing Juice |
| viral | Externo | Passing Juice |
| downloaded | Externo | Passing Juice |
| headline | Externo | Passing Juice |
| observed | Externo | Passing Juice |
| said | Externo | Passing Juice |
| Ethan Mollick | Externo | Passing Juice |
| series | Externo | Passing Juice |
| essay | Externo | Passing Juice |
| aspires to deliver | Externo | Passing Juice |
| recently backed | Externo | Passing Juice |
| pursued | Externo | Passing Juice |
| tempted | Externo | Passing Juice |
| discussed | Externo | Passing Juice |
| elsewhere | Interno | Passing Juice |
| news | Externo | Passing Juice |
| Unbound | Externo | Passing Juice |
| enhances | Externo | Passing Juice |
| works | Externo | Passing Juice |
| 2 | Interno | Passing Juice |
| 3 | Interno | Passing Juice |
| 84 | Interno | Passing Juice |
| E-mail me | Externo | Passing Juice |
| Privacy Policy | Interno | Passing Juice |
| Terms of Use | Interno | Passing Juice |
| Perception Builder | Externo | Passing Juice |
SEO Keywords
Keywords Cloud
all traverse from biotech damon subscribe runyon timmerman more cancer
Consistenza Keywords
| Keyword | Contenuto | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| timmerman | 38 |  |
 |
|
|
| more | 26 | |
|
|
|
| cancer | 24 | |
|
|
|
| biotech | 20 | |
|
|
|
| runyon | 19 | |
|
|
|
Usabilita
Url
Dominio : timmermanreport.com
Lunghezza : 19
Favicon
Grande, il tuo sito usa una favicon.
Stampabilita
Non abbiamo riscontrato codice CSS Print-Friendly.
Lingua
Buono. La tua lingua dichiarata en.
Dublin Core
Questa pagina non sfrutta i vantaggi di Dublin Core.
Documento
Doctype
HTML 5
Encoding
Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Validita W3C
Errori : 0
Avvisi : 0
Email Privacy
Attenzione! E stato trovato almeno un indirizzo mail in plain text. Usa antispam protector gratuito per nascondere gli indirizzi mail agli spammers.
Deprecated HTML
Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Suggerimenti per velocizzare
|
Eccellente, il tuo sito web non utilizza nested tables. |
|
Molto male, il tuo sito web utilizza stili CSS inline. |
|
Molto male, il tuo sito web ha troppi file CSS files (piu di 4). |
|
Molto male, il tuo sito web ha troppi file JS (piu di 6). |
|
Peccato, il vostro sito non approfitta di gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Ottimizzazione
XML Sitemap
Grande, il vostro sito ha una sitemap XML.
| https://timmermanreport.com/sitemap_index.xml |
Robots.txt
https://timmermanreport.com/robots.txt
Grande, il vostro sito ha un file robots.txt.
Analytics
Grande, il vostro sito ha uno strumento di analisi dei dati.
Google Analytics |
PageSpeed Insights
Dispositivo
Categorie
Free SEO Testing Tool
Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web